110 related articles for article (PubMed ID: 10025446)
1. Androgen replacement in a 48, XXYY-male patient.
Heuser I; Hartmann A; Oertel H
Arch Gen Psychiatry; 1999 Feb; 56(2):194-5. PubMed ID: 10025446
[No Abstract] [Full Text] [Related]
2. [De La Chapelle syndrome].
Dupuy O; Palou M; Mayaudon H; Sarret D; Bordier L; Garcin JM; Bauduceau B
Presse Med; 2001 Mar; 30(8):369-72. PubMed ID: 11268892
[TBL] [Abstract][Full Text] [Related]
3. An XXYY male with schizophrenia.
Lee JW
Aust N Z J Psychiatry; 1996 Aug; 30(4):553-6. PubMed ID: 8887709
[TBL] [Abstract][Full Text] [Related]
4. Unexpectedly prolonged washout period of exogenous testosterone after discontinuation of intramuscular testosterone undecanoate depot injection (Nebido(®) or Reandron(®) ) in men with congenital hypogonadotrophic hypogonadism.
Gan EH; Bouloux PM; Quinton R
Clin Endocrinol (Oxf); 2016 Jun; 84(6):947-50. PubMed ID: 26732131
[No Abstract] [Full Text] [Related]
5. Gonadotropin dynamics in XX males.
Pérez-Palacios G; Medina M; Ullao-Aguirre A; Chávez BA; Villareal G; Dutrem MT; Cahill LT; Wachtel S
J Clin Endocrinol Metab; 1981 Aug; 53(2):254-7. PubMed ID: 6788790
[TBL] [Abstract][Full Text] [Related]
6. Congenital heart disease in the 48,XXYY syndrome.
Meschede D; Nekarda T; Kececioglu D; Löser H; Vogt J; Miny P; Horst J
Clin Genet; 1995 Aug; 48(2):100-2. PubMed ID: 7586648
[TBL] [Abstract][Full Text] [Related]
7. Endocrine function and diagnostic problems in a prepubertal case of 48,XXYY.
Vigi V; Pinca A; Guerrini P; Scappaticci S; Volpato S
J Genet Hum; 1978 Dec; 26(4):411-7. PubMed ID: 571897
[TBL] [Abstract][Full Text] [Related]
8. [Partial androgen deficiency in the aging male: diagnosis and therapy].
John H; Tenti G; Hauri D
Praxis (Bern 1994); 2002 Aug; 91(33):1289-94. PubMed ID: 12224409
[TBL] [Abstract][Full Text] [Related]
9. X;Y translocation in an adolescent mentally normal phenotypic male with features of hypogonadism.
Bernstein R; Pinto MR; Almeida M; Solarsh SM; Meck J; Jenkins T
J Med Genet; 1980 Dec; 17(6):437-43. PubMed ID: 6937619
[TBL] [Abstract][Full Text] [Related]
10. The XX male -- report on a child and an adult.
Bauch K; Witkowski R; Ullrich E; Dempe A; Lindner J
Endokrinologie; 1980 Jul; 76(1):63-7. PubMed ID: 7192212
[TBL] [Abstract][Full Text] [Related]
11. Congenital camptodactyly associated with the 48,XXYY syndrome.
Bosch AM; Hack WW; Schrander-Stumpel CT
Genet Couns; 1998; 9(1):19-21. PubMed ID: 9555582
[TBL] [Abstract][Full Text] [Related]
12. [48,XXYY syndrome in a boy with essential tremor. Comparison with 120 cases from the literature].
Donati F; Gasser S; Mullis P; Braga S; Vassella F
Monatsschr Kinderheilkd; 1992 Apr; 140(4):216-9. PubMed ID: 1614446
[TBL] [Abstract][Full Text] [Related]
13. Familial cytomegalic adrenocortical hypoplasia: an X-linked syndrome of pubertal failure.
Hay ID; Smail PJ; Forsyth CC
Arch Dis Child; 1981 Sep; 56(9):715-21. PubMed ID: 7197507
[TBL] [Abstract][Full Text] [Related]
14. Androgen receptor gene CAG repeat length and body mass index modulate the safety of long-term intramuscular testosterone undecanoate therapy in hypogonadal men.
Zitzmann M; Nieschlag E
J Clin Endocrinol Metab; 2007 Oct; 92(10):3844-53. PubMed ID: 17635942
[TBL] [Abstract][Full Text] [Related]
15. Bloom's syndrome, missing Y, hypogonadism and cancer.
Shabtai F; Halbrecht I
Clin Genet; 1980 Jul; 18(1):93-5. PubMed ID: 7418260
[No Abstract] [Full Text] [Related]
16. Retrospective investigation of testosterone undecanoate depot for the long-term treatment of male hypogonadism in clinical practice.
Conaglen HM; Paul RG; Yarndley T; Kamp J; Elston MS; Conaglen JV
J Sex Med; 2014 Feb; 11(2):574-82. PubMed ID: 24279472
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics, efficacy, and safety of a permeation-enhanced testosterone transdermal system in comparison with bi-weekly injections of testosterone enanthate for the treatment of hypogonadal men.
Dobs AS; Meikle AW; Arver S; Sanders SW; Caramelli KE; Mazer NA
J Clin Endocrinol Metab; 1999 Oct; 84(10):3469-78. PubMed ID: 10522982
[TBL] [Abstract][Full Text] [Related]
18. Current status of testosterone substitution therapy.
Nieschlag E
Int J Androl; 1982 Jun; 5(3):225-8. PubMed ID: 7118263
[No Abstract] [Full Text] [Related]
19. Testosterone replacement therapy does not promote priapism in hypogonadal men with sickle cell disease: 12-month safety report.
Morrison BF; Reid M; Madden W; Burnett AL
Andrology; 2013 Jul; 1(4):576-82. PubMed ID: 23606509
[TBL] [Abstract][Full Text] [Related]
20. Testosterone treatment of hypogonadal men participating in competitive sports.
Gooren LJ; Behre HM
Andrologia; 2008 Jun; 40(3):195-9. PubMed ID: 18477208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
